empagliflozin; linagliptin · Boehringer Ingelheim · NDA 206073
Glyxambi
Earliest generic entry, as listed · earliest of 2 marketed strengths
8 Dec 2037
Blocked by patent: US 12364700.
Listed patents · 28 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12364700 | — | 8 Dec 2037 |
| US 12364700 | use U-4224 | 8 Jun 2037 |
| US 10258637 | — | 3 Oct 2034 |
| US 11090323 | — | 3 Oct 2034 |
| US 11833166 | — | 3 Oct 2034 |
| US 12433906 | — | 3 Oct 2034 |
| US 9949998 | use U-2290 | 11 Jun 2034 |
| US 10258637 | use U-2290 | 3 Apr 2034 |
| US 11090323 | use U-3191 | 3 Apr 2034 |
| US 11833166 | use U-3776 | 3 Apr 2034 |
| US 11833166 | use U-3777 | 3 Apr 2034 |
| US 12433906 | use U-4295 | 3 Apr 2034 |
| US 12433906 | use U-4294 | 3 Apr 2034 |
| US 12433906 | use U-4293 | 3 Apr 2034 |
| US 12433906 | use U-4304 | 3 Apr 2034 |
| US 12433906 | use U-4296 | 3 Apr 2034 |
| US 12115179 | — | 11 Aug 2030 |
| US 8551957 | — | 14 Apr 2030 |
| US 12115179 | use U-4023 | 11 Feb 2030 |
| US 8551957 | product, use U-1651 | 14 Oct 2029 |
| US 7579449 | — | 1 Feb 2029 |
| US 7579449 | substance | 1 Aug 2028 |
| US 11033552 | — | 4 Nov 2027 |
| US 8673927 | — | 4 Nov 2027 |
| US 7713938 | — | 15 Oct 2027 |
| US 11033552 | product | 4 May 2027 |
| US 12178819 | product | 4 May 2027 |
| US 7713938 | substance, product | 15 Apr 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 206073 · 001 · RLD | tablet, oral | 10MG;5MG | 8 Dec 2037 |
| 206073 · 002 · RLD | tablet, oral | 25MG;5MG | 8 Dec 2037 |
Expired or delisted (4)
- US 8673927 · use U-1652 · 4 May 2027 · delisted
- US 9173859 · product, use U-1772 · 4 May 2027 · delisted
- US 8883805 · — · 26 May 2026
- US 8883805 · product · 26 Nov 2025